White, Petrovitch, et al., Prevalence of dementia in older Japanese-American men in Hawaii.

Ono, Hasegawa, et al., Curcumin has potent anti-amyloidogenic effects for Alzheimer’s beta-amyloid fibrils in vitro.

F. Yang, Lim, et al., Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.

Belviranli, Okudan, et al., Curcumin improves spatial memory and decreases oxidative damage in aged female rats.

Baum, Lam, et al., Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease.

M. Taylor, Moore, et al., Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer’s Aβ peptide.

Popper, The Logic of Scientific Discovery, p. 316.

Глава двадцать первая. Колумбийские подсказки

Lemere, Lopera, et al., The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology.

Sepulveda-Falla, Glatzel, Lopera, Phenotypic profile of early-onset familial Alzheimer’s disease caused by presenilin-1 E280A mutation.

Belluck, Alzheimer’s Stalks a Colombian Family.

Глава двадцать вторая. Наследие Альцгеймера

Brookmeyer, Johnson, et al., Forecasting the global burden of Alzheimer’s disease.

Zissimopoulos, Crimmins, St Clair, The value of delaying Alzheimer’s disease onset.

De Strooper and Karran, The cellular phase of Alzheimer’s disease.

Kallo, Emri, et al., Changes in the chemical barrier composition of tears in Alzheimer’s disease reveal potential tear diagnostic biomarkers.

Kaiser, What does a disease deserve?

Herper, The coming boom in brain medicines.